Transcend Therapeutics Funding: $42M Raised, Series A (2023)
Transcend Therapeutics is based in New York, NY. It has raised $42M in total funding. Latest round: Series A.
Transcend Therapeutics funding overview
Transcend Therapeutics is based in New York, NY. Transcend Therapeutics has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2023. The round record for Transcend Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Alpha Wave Global, Integrated Investment Partners. 2 distinct backers are named across the disclosed rounds.
Transcend Therapeutics at a glance
Total raised
$42M
Latest round
Series A
Latest round date
February 2023
Headquarters
New York, NY
Notable investors
Alpha Wave Global, Integrated Investment Partners
Frequently asked about Transcend Therapeutics funding
How much has Transcend Therapeutics raised?
Transcend Therapeutics has raised $42M in total disclosed funding across the rounds on record.
Who has invested in Transcend Therapeutics?
Alpha Wave Global, Integrated Investment Partners are named among the investors backing Transcend Therapeutics.
What was the latest Transcend Therapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2023.
Where is Transcend Therapeutics based?
Transcend Therapeutics is based in New York, NY.
When did Transcend Therapeutics last raise?
The last disclosed Transcend Therapeutics round closed in February 2023 at Series A.
Every Transcend Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New York at a similar stage.
